Loading…

Phenotype of Chronic Obstructive Pulmonary Disease Based on Computed Tomography–Defined Underlying Pathology

Chronic obstructive pulmonary disease (COPD) is a complex and heterogeneous disease. Not all patients with COPD respond to available drugs. Identifying respondents to therapy is critical to delivering the most appropriate treatment and avoiding unnecessary medication. Recognition of individual patie...

Full description

Saved in:
Bibliographic Details
Published in:Tuberculosis and respiratory diseases 2022-10, Vol.85 (4), p.302-312
Main Author: Kim, Won-Dong
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c430t-5d2f1fcad4750c57d3a11a7d0aa74f0b144d326f85d75e5b25373f7af52a68bb3
cites cdi_FETCH-LOGICAL-c430t-5d2f1fcad4750c57d3a11a7d0aa74f0b144d326f85d75e5b25373f7af52a68bb3
container_end_page 312
container_issue 4
container_start_page 302
container_title Tuberculosis and respiratory diseases
container_volume 85
creator Kim, Won-Dong
description Chronic obstructive pulmonary disease (COPD) is a complex and heterogeneous disease. Not all patients with COPD respond to available drugs. Identifying respondents to therapy is critical to delivering the most appropriate treatment and avoiding unnecessary medication. Recognition of individual patients’ dominant characteristics by phenotype is a useful tool to better understand their disease and tailor treatment accordingly. To look for a suitable phenotype, it is important to understand what makes COPD complex and heterogeneous. The pathology of COPD includes small airway disease and/or emphysema. Thus, COPD is not a single disease entity. In addition, there are two types (panlobular and centrilobular) of emphysema in COPD. The coexistence of different pathological subtypes could be the reason for the complexity and heterogeneity of COPD. Thus, it is necessary to look for the phenotype based on the difference in the underlying pathology. Review of the literature has shown that clinical manifestation and therapeutic response to pharmacological therapy are different depending on the presence of computed tomography–defined airway wall thickening in COPD patients. Defining the phenotype of COPD based on the underlying pathology is encouraging as most clinical manifestations can be distinguished by the presence of increased airway wall thickness. Pharmacological therapy has shown significant effect on COPD with airway wall thickening. However, it has limited use in COPD without an airway disease. The phenotype of COPD based on the underlying pathology can be a useful tool to better understand the disease and adjust treatment accordingly.
doi_str_mv 10.4046/trd.2022.0029
format article
fullrecord <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_0574c573841c40a795c48208ed42cb0c</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_0574c573841c40a795c48208ed42cb0c</doaj_id><sourcerecordid>2689053215</sourcerecordid><originalsourceid>FETCH-LOGICAL-c430t-5d2f1fcad4750c57d3a11a7d0aa74f0b144d326f85d75e5b25373f7af52a68bb3</originalsourceid><addsrcrecordid>eNpVkctu1TAQhi0EoofCkn2WbHLwNXY2SHDKpVKlnkW7thxfklSJHWynUna8A2_Ik-DDqZC6mRnNjL5_Rj8A7xHcU0ibjzmaPYYY7yHE7QuwwxCyukGCvgQ7xImoCSPNBXiT0gOEDWmFeA0uCBMYE8R3wB8H60PeFlsFVx2GGPyoq9su5bjqPD7a6rhOc_AqbtXVmKxKtvpSgqmCrw5hXtZc6rswhz6qZdj-_Pp9Zd3oS_PeGxunbfR9dVR5CFPot7fglVNTsu-e8iW4__b17vCjvrn9fn34fFNrSmCumcEOOa0M5Qxqxg1RCCluoFKcOtghSg3BjRPMcGZZhxnhxHHlGFaN6DpyCa7PXBPUg1ziOJcHZFCj_NcIsZcq5lFPVkLGaZEggiJNoeIt01RgKKyhWHdQF9anM2tZu9kabX2OanoGfT7x4yD78CjbclXDRAF8eALE8HO1Kct5TNpOk_I2rEniRrSQEYxYWa3PqzqGlKJ1_2UQlCe_ZfFbnvyWJ7_JX2Nkn-U</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2689053215</pqid></control><display><type>article</type><title>Phenotype of Chronic Obstructive Pulmonary Disease Based on Computed Tomography–Defined Underlying Pathology</title><source>Open Access: PubMed Central</source><creator>Kim, Won-Dong</creator><creatorcontrib>Kim, Won-Dong</creatorcontrib><description>Chronic obstructive pulmonary disease (COPD) is a complex and heterogeneous disease. Not all patients with COPD respond to available drugs. Identifying respondents to therapy is critical to delivering the most appropriate treatment and avoiding unnecessary medication. Recognition of individual patients’ dominant characteristics by phenotype is a useful tool to better understand their disease and tailor treatment accordingly. To look for a suitable phenotype, it is important to understand what makes COPD complex and heterogeneous. The pathology of COPD includes small airway disease and/or emphysema. Thus, COPD is not a single disease entity. In addition, there are two types (panlobular and centrilobular) of emphysema in COPD. The coexistence of different pathological subtypes could be the reason for the complexity and heterogeneity of COPD. Thus, it is necessary to look for the phenotype based on the difference in the underlying pathology. Review of the literature has shown that clinical manifestation and therapeutic response to pharmacological therapy are different depending on the presence of computed tomography–defined airway wall thickening in COPD patients. Defining the phenotype of COPD based on the underlying pathology is encouraging as most clinical manifestations can be distinguished by the presence of increased airway wall thickness. Pharmacological therapy has shown significant effect on COPD with airway wall thickening. However, it has limited use in COPD without an airway disease. The phenotype of COPD based on the underlying pathology can be a useful tool to better understand the disease and adjust treatment accordingly.</description><identifier>ISSN: 1738-3536</identifier><identifier>EISSN: 2005-6184</identifier><identifier>DOI: 10.4046/trd.2022.0029</identifier><identifier>PMID: 35822317</identifier><language>eng</language><publisher>The Korean Academy of Tuberculosis and Respiratory Diseases</publisher><subject>centrilobular emphysema ; chronic obstructive pulmonary disease ; emphysema ; panlobular emphysema ; phenotype ; Review ; small airway disease</subject><ispartof>Tuberculosis and respiratory diseases, 2022-10, Vol.85 (4), p.302-312</ispartof><rights>Copyright © 2022 The Korean Academy of Tuberculosis and Respiratory Diseases 2022</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c430t-5d2f1fcad4750c57d3a11a7d0aa74f0b144d326f85d75e5b25373f7af52a68bb3</citedby><cites>FETCH-LOGICAL-c430t-5d2f1fcad4750c57d3a11a7d0aa74f0b144d326f85d75e5b25373f7af52a68bb3</cites><orcidid>0000-0003-0141-1971</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC9537658/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC9537658/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,724,777,781,882,27905,27906,53772,53774</link.rule.ids></links><search><creatorcontrib>Kim, Won-Dong</creatorcontrib><title>Phenotype of Chronic Obstructive Pulmonary Disease Based on Computed Tomography–Defined Underlying Pathology</title><title>Tuberculosis and respiratory diseases</title><description>Chronic obstructive pulmonary disease (COPD) is a complex and heterogeneous disease. Not all patients with COPD respond to available drugs. Identifying respondents to therapy is critical to delivering the most appropriate treatment and avoiding unnecessary medication. Recognition of individual patients’ dominant characteristics by phenotype is a useful tool to better understand their disease and tailor treatment accordingly. To look for a suitable phenotype, it is important to understand what makes COPD complex and heterogeneous. The pathology of COPD includes small airway disease and/or emphysema. Thus, COPD is not a single disease entity. In addition, there are two types (panlobular and centrilobular) of emphysema in COPD. The coexistence of different pathological subtypes could be the reason for the complexity and heterogeneity of COPD. Thus, it is necessary to look for the phenotype based on the difference in the underlying pathology. Review of the literature has shown that clinical manifestation and therapeutic response to pharmacological therapy are different depending on the presence of computed tomography–defined airway wall thickening in COPD patients. Defining the phenotype of COPD based on the underlying pathology is encouraging as most clinical manifestations can be distinguished by the presence of increased airway wall thickness. Pharmacological therapy has shown significant effect on COPD with airway wall thickening. However, it has limited use in COPD without an airway disease. The phenotype of COPD based on the underlying pathology can be a useful tool to better understand the disease and adjust treatment accordingly.</description><subject>centrilobular emphysema</subject><subject>chronic obstructive pulmonary disease</subject><subject>emphysema</subject><subject>panlobular emphysema</subject><subject>phenotype</subject><subject>Review</subject><subject>small airway disease</subject><issn>1738-3536</issn><issn>2005-6184</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>DOA</sourceid><recordid>eNpVkctu1TAQhi0EoofCkn2WbHLwNXY2SHDKpVKlnkW7thxfklSJHWynUna8A2_Ik-DDqZC6mRnNjL5_Rj8A7xHcU0ibjzmaPYYY7yHE7QuwwxCyukGCvgQ7xImoCSPNBXiT0gOEDWmFeA0uCBMYE8R3wB8H60PeFlsFVx2GGPyoq9su5bjqPD7a6rhOc_AqbtXVmKxKtvpSgqmCrw5hXtZc6rswhz6qZdj-_Pp9Zd3oS_PeGxunbfR9dVR5CFPot7fglVNTsu-e8iW4__b17vCjvrn9fn34fFNrSmCumcEOOa0M5Qxqxg1RCCluoFKcOtghSg3BjRPMcGZZhxnhxHHlGFaN6DpyCa7PXBPUg1ziOJcHZFCj_NcIsZcq5lFPVkLGaZEggiJNoeIt01RgKKyhWHdQF9anM2tZu9kabX2OanoGfT7x4yD78CjbclXDRAF8eALE8HO1Kct5TNpOk_I2rEniRrSQEYxYWa3PqzqGlKJ1_2UQlCe_ZfFbnvyWJ7_JX2Nkn-U</recordid><startdate>20221001</startdate><enddate>20221001</enddate><creator>Kim, Won-Dong</creator><general>The Korean Academy of Tuberculosis and Respiratory Diseases</general><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0003-0141-1971</orcidid></search><sort><creationdate>20221001</creationdate><title>Phenotype of Chronic Obstructive Pulmonary Disease Based on Computed Tomography–Defined Underlying Pathology</title><author>Kim, Won-Dong</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c430t-5d2f1fcad4750c57d3a11a7d0aa74f0b144d326f85d75e5b25373f7af52a68bb3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>centrilobular emphysema</topic><topic>chronic obstructive pulmonary disease</topic><topic>emphysema</topic><topic>panlobular emphysema</topic><topic>phenotype</topic><topic>Review</topic><topic>small airway disease</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kim, Won-Dong</creatorcontrib><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>Directory of Open Access Journals (DOAJ)</collection><jtitle>Tuberculosis and respiratory diseases</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kim, Won-Dong</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Phenotype of Chronic Obstructive Pulmonary Disease Based on Computed Tomography–Defined Underlying Pathology</atitle><jtitle>Tuberculosis and respiratory diseases</jtitle><date>2022-10-01</date><risdate>2022</risdate><volume>85</volume><issue>4</issue><spage>302</spage><epage>312</epage><pages>302-312</pages><issn>1738-3536</issn><eissn>2005-6184</eissn><abstract>Chronic obstructive pulmonary disease (COPD) is a complex and heterogeneous disease. Not all patients with COPD respond to available drugs. Identifying respondents to therapy is critical to delivering the most appropriate treatment and avoiding unnecessary medication. Recognition of individual patients’ dominant characteristics by phenotype is a useful tool to better understand their disease and tailor treatment accordingly. To look for a suitable phenotype, it is important to understand what makes COPD complex and heterogeneous. The pathology of COPD includes small airway disease and/or emphysema. Thus, COPD is not a single disease entity. In addition, there are two types (panlobular and centrilobular) of emphysema in COPD. The coexistence of different pathological subtypes could be the reason for the complexity and heterogeneity of COPD. Thus, it is necessary to look for the phenotype based on the difference in the underlying pathology. Review of the literature has shown that clinical manifestation and therapeutic response to pharmacological therapy are different depending on the presence of computed tomography–defined airway wall thickening in COPD patients. Defining the phenotype of COPD based on the underlying pathology is encouraging as most clinical manifestations can be distinguished by the presence of increased airway wall thickness. Pharmacological therapy has shown significant effect on COPD with airway wall thickening. However, it has limited use in COPD without an airway disease. The phenotype of COPD based on the underlying pathology can be a useful tool to better understand the disease and adjust treatment accordingly.</abstract><pub>The Korean Academy of Tuberculosis and Respiratory Diseases</pub><pmid>35822317</pmid><doi>10.4046/trd.2022.0029</doi><tpages>11</tpages><orcidid>https://orcid.org/0000-0003-0141-1971</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1738-3536
ispartof Tuberculosis and respiratory diseases, 2022-10, Vol.85 (4), p.302-312
issn 1738-3536
2005-6184
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_0574c573841c40a795c48208ed42cb0c
source Open Access: PubMed Central
subjects centrilobular emphysema
chronic obstructive pulmonary disease
emphysema
panlobular emphysema
phenotype
Review
small airway disease
title Phenotype of Chronic Obstructive Pulmonary Disease Based on Computed Tomography–Defined Underlying Pathology
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-20T20%3A49%3A44IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Phenotype%20of%20Chronic%20Obstructive%20Pulmonary%20Disease%20Based%20on%20Computed%20Tomography%E2%80%93Defined%20Underlying%20Pathology&rft.jtitle=Tuberculosis%20and%20respiratory%20diseases&rft.au=Kim,%20Won-Dong&rft.date=2022-10-01&rft.volume=85&rft.issue=4&rft.spage=302&rft.epage=312&rft.pages=302-312&rft.issn=1738-3536&rft.eissn=2005-6184&rft_id=info:doi/10.4046/trd.2022.0029&rft_dat=%3Cproquest_doaj_%3E2689053215%3C/proquest_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c430t-5d2f1fcad4750c57d3a11a7d0aa74f0b144d326f85d75e5b25373f7af52a68bb3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2689053215&rft_id=info:pmid/35822317&rfr_iscdi=true